ScienceDex / Researcher record
Andrew R Draganski
- Atticus Pharma Inc (no department on record)
- Zylo Therapeutics, Inc. (no department on record)
From the FY2026 NIH awards this investigator leads as contact PI. The department is the award's.
FY2026 NIH rank #8,929
- Rising Star
- Early Career
NIH Funding · FY2026
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
Linked awards ($M)Award-linked rank
View yearly values
| Fiscal year | Linked awards | Records | Rank |
|---|---|---|---|
| 2024 | $145,888 | 1 | #49,897 |
| 2025 | $300,000 | 1 | #41,637 |
| 2026 | $2,272,829 | 3 | #8,929 |
Award activity
Awards through the years
NIH award records listing this researcher in each fiscal year.
- FY20241 record
- FY20251 record
- FY2026 · selected3 records
Each bar starts at zero. Annual records can include renewals of the same project; they are not a count of distinct career grants.
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID 14514077Search this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2024 through FY2026Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2027.
FY2026 award records by amount
NIH award records listing Andrew R Draganski as a PI. Multi-PI records show the full award amount for context.
- 1R44AR087266-01A1R44Contact PIPhase 2: Development of an endocannabinoid microparticle formulation for the topical treatment of cutaneous manifestations of lupus erythematosus$1Maward amount
- 2R44DK129147-02R44Contact PIPhase II: Optimization of a nanoparticle-based topical PDE5i formulation for treatment of erectile dysfunction$965.7Kaward amount
- 5R41AI188793-02R41Contact PIDevelopment and optimization of a nitric oxide releasing microparticle formulation for the topical treatment of chronic rhinosinusitis$300Kaward amount
Award organizations
Organizations that administered FY2026 awards listing Andrew R Draganski as a PI.
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2024First NIH AwardAtticus Pharma Inc
- 2025Multi-Institutional ResearchAwards at 2 institutions
- 2026$500K Cumulative Funding
- 2026$1M Cumulative Funding
- 2026$2M Cumulative Funding
- 2026Entered Top 50% NationallyRanked #8929
Shared-award investigators
Other investigators listed on at least one of the same NIH award records as Andrew R Draganski.